ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Dawnrays Pharmaceutical (2348.HK)
Dawnrays Pharmaceutical share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$0.945▲ 0.00%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Dawnrays Pharmaceutical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Dawnrays Pharmaceutical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Dawnrays Pharmaceutical a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$0.910 and HK$0.988; in 9 out of 10, between HK$0.846 and HK$1.06. Estimated annual volatility is 23%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$1.4B
- Market cap (USD)
- $180M
- P/E ratio
- 5.5
- Dividend yield
- 5.69%
- 52-week high
- HK$1.25
- 52-week low
- HK$0.930
- Revenue (12 months)
- CN¥1.1B
- Gross margin
- 45.4%
- Operating margin
- 21.2%
- Net margin
- 20.3%
- Beta
- 0.26
What this means
ATLAS does not publish a fair value for 2348.HK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 2348.HK has traded between HK$0.930 and HK$1.25. Today it is 24.4% below that high and 2% above its low.
On the business: net margin is 20.3%; it trades at 5.5 times earnings.
Its beta is 0.26: it tends to move less than the market.
About the company
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs.
Want to see everything about Dawnrays Pharmaceutical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Dawnrays Pharmaceutical do?
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs.
What is the chance 2348.HK goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, 2348.HK ends the month between HK$0.910 and HK$0.988.
How big is Dawnrays Pharmaceutical and what is its P/E ratio?
Dawnrays Pharmaceutical's market capitalization is HK$1.4B. Its price-to-earnings (P/E) ratio is 5.5: you pay HK$5.53 for each HK$1.00 of yearly earnings.
Does Dawnrays Pharmaceutical pay a dividend?
Yes. 2348.HK's current dividend yield is 5.69% at today's price (HK$0.945).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer